We are live on ! Find out more
QF

QVT Financial Portfolio holdings

AUM $1.37B
1-Year Est. Return 148.1%
This Fund
S&P 500
This Quarter Est. Return
+5.72%
1 Year Est. Return
+148.1%
3 Year Est. Return
+280.64%
5 Year Est. Return
+413.55%
10 Year Est. Return
+2,213.36%
AUM
$953M
AUM Growth
-$819M
Cap. Flow
-$1.21B
Cap. Flow %
-127.13%
Top 10 Hldgs %
71.93%
Holding
67
New
7
Increased
8
Reduced
17
Closed
14

Sector Composition

Rank Sector Weight
1 Healthcare 10.32%
2 Consumer Discretionary 6.23%
3 Communication Services 5.77%
4 Energy 4%
5 Technology 1.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GS icon
51
Goldman Sachs
GS
$305B
-56,832
Closed -$14.5M
HIMX
52
Himax Technologies
HIMX
$2.09B
-483,500
Closed -$5.04M
IBKR icon
53
Interactive Brokers
IBKR
$40.5B
-845,096
Closed -$12.5M
NAT icon
54
Nordic American Tanker
NAT
$1.35B
-3,703,929
Closed -$8.48M
QRVO icon
55
Qorvo
QRVO
$8.09B
-105,000
Closed -$6.99M
RDFN
56
DELISTED
Redfin
RDFN
-7,970
Closed -$250K
TCOM icon
57
Trip.com Group
TCOM
$28.5B
-113,300
Closed -$5M
SIOX
58
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
-9,375,000
Closed -$395M
MYOV
59
DELISTED
Myovant Sciences Ltd.
MYOV
-37,231,342
Closed -$471M
TWX
60
DELISTED
Time Warner Inc
TWX
-228,244
Closed -$20.9M

Similar funds

QVT Financial's Q1 2018 Portfolio in Review

As of Q1 2018, QVT Financial held 67 positions worth $953M, down 46% from $1.77B the previous quarter. Its ten largest holdings account for 72% of the portfolio.

QVT Financial withdrew a net $1.21B in Q1 2018, closing 14 positions and reducing 17 holdings. Its most notable exit was Myovant Sciences Ltd., an estimated $471M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 10% of assets, down from 58% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, QVT Financial opened a new position in FTS International, Inc. Common Stock worth $14.8M.

  • QVT Financial's largest Q1 2018 buy was FTS International, Inc. Common Stock: 40,219 shares worth $14.8M.
  • QVT Financial added most to State Street SPDR S&P Biotech ETF in Q1 2018, an estimated $38.3M increase.
  • QVT Financial's biggest Q1 2018 reduction was MakeMyTrip, cutting an estimated $6.91M.
  • QVT Financial fully exited Myovant Sciences Ltd. in Q1 2018, selling an estimated $471M.
  • QVT Financial's ten largest holdings make up 72% of its $953M portfolio in Q1 2018.
  • QVT Financial opened 7 new positions and closed 14 in Q1 2018.
  • QVT Financial's portfolio value fell 46% quarter-over-quarter to $953M.

Based on QVT Financial's 13F filing for Q1 2018, filed 15 May 2018.